Status:
COMPLETED
Predictors for Nasal Intermittent Positive Pressure Ventilation Failure for Premature Infants With Respiratory Distress Syndrome
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Respiratory Distress Syndrome, Newborn
Premature
Eligibility:
All Genders
Brief Summary
Non-invasive respiratory support methods have been widely used in premature babies with respiratory distress syndrome (RDS) which has changed the basic management of premature babies in the early peri...
Eligibility Criteria
Inclusion
- \<32 weeks preterm babies
- Those who have received nasal intermittent positive pressure ventilation
Exclusion
- Babies born\> 32 weeks
- Babies with congenital anomalies
- Babies who have intubated in the delivery room
- Babies whose parents refuse to participitate
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
397 Patients enrolled
Trial Details
Trial ID
NCT05260424
Start Date
December 1 2020
End Date
February 1 2024
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara City Hospital Bilkent
Ankara, Turkey (Türkiye), 06000